ACOFIDE Trademark

Trademark Overview

On Friday, May 24, 2013, a trademark application was filed for ACOFIDE with the United States Patent and Trademark Office. The USPTO has given the ACOFIDE trademark a serial number of 79132262. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, May 24, 2023. This trademark is owned by ZERIA Pharmaceutical Co., Ltd.. The ACOFIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders
acofide

General Information

Serial Number79132262
Word MarkACOFIDE
Filing DateFriday, May 24, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, May 24, 2023
Registration Number4493124
Registration DateTuesday, March 11, 2014
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements

Description of MarkThe mark consists of the stylized wording "ACOFIDE".
Goods and ServicesPharmaceutical preparations for the treatment of gastrointestinal diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZERIA Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8351
JP
Party NameZERIA Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameZERIA Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Sunday, December 10, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, December 10, 2023DEATH OF INTERNATIONAL REGISTRATION
Monday, March 7, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, February 14, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, February 14, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Monday, March 11, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, July 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 31, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 15, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 15, 2014FINAL DISPOSITION PROCESSED
Wednesday, June 11, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 11, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 4, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 18, 2013ASSIGNED TO LIE
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 26, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 26, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 26, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 30, 2013REFUSAL PROCESSED BY IB
Thursday, September 12, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 12, 2013REFUSAL PROCESSED BY MPU
Thursday, September 12, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 11, 2013NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2013ASSIGNED TO EXAMINER
Tuesday, July 16, 2013APPLICATION FILING RECEIPT MAILED
Friday, July 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 11, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

acofide diseases disorders gastrointestinal treatment preparations pharmaceutical